Integrated single-cell and Mendelian randomization analyses prioritize immune-related candidate genes and pathways in proliferative diabetic retinopathy
Author:
Corresponding Author:

Zi-Zhong Hu and Ping Xie. Department of Ophthalmology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China. huzizhong@njmu.edu.cn; xieping9@njmu.edu.cn

Affiliation:

Clc Number:

Fund Project:

Supported by the National Natural Science Foundation of China (No.82371076; No.82471095); the Medical-Engineering Interdisciplinary Translational Fund of the First Affiliated Hospital of Nanjing Medical University (No.QG202405).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    AIM: To prioritize immune-related candidate genes and pathways, elucidate immune dysregulation mechanisms, and provide potential therapeutic targets for diabetic retinopathy (DR). METHODS: Single-cell RNA sequencing (scRNA-seq) analysis was performed using fibrovascular membranes (FVMs) obtained from patients with proliferative diabetic retinopathy (PDR) and from normal retinas. Differentially expressed genes (DEGs) were identified by comparing FVMs to normal retinas, followed by gene set enrichment analysis (GSEA) to characterize immune-related pathways enriched in cell populations. Additionally, Mendelian randomization (MR) analysis was performed to explore the causal associations between immune cell traits and PDR. By integrating single-nucleotide polymorphism (SNP)-annotated genes with PDR scRNA-seq profiles, intersection analysis was performed to prioritize key genes within pathways enriched in PDR major cell populations through MR analysis. The prioritized candidate genes were subsequently validated in human retinal endothelial cells (hRECs) and human monocytic leukemia cell line (THP-1) cells, which were exposed to inflammatory condition. RESULTS: scRNA-seq analysis demonstrated that the major cell populations within FVMs from patients with PDR consisted of macrophages, monocytes, T cells, B cells, retinal vascular endothelial cells, fibroblasts, and pericytes. MR analysis prioritized two immune-cell traits as potential risk factors for PDR, including CD8 on CM CD8br [odds ratio (OR)=1.077, 95%CI: 1.017–1.140] and HLA DR on CD14+CD16− monocytes (OR=1.079, 95%CI: 1.034–1.126); instrumental SNPs for the two prioritized immune traits were located near genes, including CD8 on CM CD8br (ZMAT4, ZBTB16, PIP5K1B, and CD8A) and HLA DR on CD14+CD16− monocytes (GLI2, KATNIP, LYZ, ERBB4, UQCC2, WDR72, RYR2, ZNF442, and FLJ12825). Among these, CD8A mapped to the HALLMARK_ALLOGRAFT_REJECTION pathway, which was enriched in the major cell populations within FVMs from patients with PDR. Overlap analysis of genes within this pathway across major cell populations prioritized six overlapping candidate genes (CTSS, STAT1, B2M, CD74, CCL2, and TIMP1), among which CTSS was shared across all six cell types. Quantitative real-time polymerase chain reaction assays in an in vitro inflammatory microenvironment model of DR showed that CTSS expression was significantly upregulated in lipopolysaccharide (LPS)-stimulated THP-1 cells; however, no significant difference was observed in hRECs. CONCLUSION: This study prioritizes immune-related candidate genes and pathways potentially involved in PDR pathogenesis, providing exploratory value for further investigation.

    Reference
    Related
    Cited by
Get Citation

Ying Gao, Feng Yan, Jing-Fan Wang, et al. Integrated single-cell and Mendelian randomization analyses prioritize immune-related candidate genes and pathways in proliferative diabetic retinopathy. Int J Ophthalmol, 2026,19(12):2337-2349

Copy
Article Metrics
  • Abstract:
  • PDF:
Publication History
  • Received:August 31,2026
  • Revised:October 19,2026
  • Adopted:
  • Online: November 16,2026
  • Published: